GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Insulet Corp (MEX:PODD) » Definitions » Gross Profit

Insulet (MEX:PODD) Gross Profit : MXN27,566 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Insulet Gross Profit?

Insulet's gross profit for the three months ended in Dec. 2024 was MXN8,987 Mil. Insulet's gross profit for the trailing twelve months (TTM) ended in Dec. 2024 was MXN27,566 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Insulet's gross profit for the three months ended in Dec. 2024 was MXN8,987 Mil. Insulet's Revenue for the three months ended in Dec. 2024 was MXN12,461 Mil. Therefore, Insulet's Gross Margin % for the quarter that ended in Dec. 2024 was 72.12%.

Insulet had a gross margin of 72.12% for the quarter that ended in Dec. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Insulet was 69.79%. The lowest was 50.50%. And the median was 64.73%.


Insulet Gross Profit Historical Data

The historical data trend for Insulet's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Insulet Gross Profit Chart

Insulet Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11,583.11 15,428.58 15,705.98 19,688.43 30,151.09

Insulet Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,131.10 5,091.73 6,062.12 7,425.21 8,986.72

Competitive Comparison of Insulet's Gross Profit

For the Medical Devices subindustry, Insulet's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Insulet's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Insulet's Gross Profit distribution charts can be found below:

* The bar in red indicates where Insulet's Gross Profit falls into.


;
;

Insulet Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Insulet's Gross Profit for the fiscal year that ended in Dec. 2024 is calculated as

Gross Profit (A: Dec. 2024 )=Revenue - Cost of Goods Sold
=43204.668 - 13053.583
=30,151

Insulet's Gross Profit for the quarter that ended in Dec. 2024 is calculated as

Gross Profit (Q: Dec. 2024 )=Revenue - Cost of Goods Sold
=12461.281 - 3474.56
=8,987

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN27,566 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Insulet's Gross Margin % for the quarter that ended in Dec. 2024 is calculated as

Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=8,987 / 12461.281
=72.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Insulet  (MEX:PODD) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Insulet had a gross margin of 72.12% for the quarter that ended in Dec. 2024 => Durable competitive advantage


Insulet Gross Profit Related Terms

Thank you for viewing the detailed overview of Insulet's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Insulet Business Description

Traded in Other Exchanges
Address
100 Nagog Park, Acton, MA, USA, 01720
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.